Skip to content
Everfront Biotech Inc.
關於長弘
創辦人的話
新藥開發
EF-001 | 治療高度惡性腦瘤
EF-009 | 治療胰臟癌
智慧財產
最新消息
聯絡我們
HOME 🇺🇸
About EFB 🇺🇸
Pipelines 🇺🇸
EF-001
EF-009
Local delivery therapy of Cerebraca® Wafer being highlighted in the natural review
←
Case report – Cerebraca® Wafer implantation combined with CIK therapy for the treatment of recurrent Glioblastoma revealed superior clinical outcome (overall survival extended for more than 24 months).
📢 治療復發性惡性腦瘤 花慈團隊榮獲臨床新創獎
→